InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
TheSprinx Free
03/27/24 3:44 PM
profile icon
Monksdream PremiumMember
03/26/24 3:48 PM
profile icon
TheFinalCD PremiumMember
03/25/24 7:32 AM
profile icon
Renee PremiumMember
03/22/24 9:33 AM
profile icon
TheSprinx Free
12/29/23 4:58 PM
profile icon
INFINITI Free
09/18/23 8:49 AM
profile icon
INFINITI Free
09/15/23 8:29 AM
profile icon
INFINITI Free
09/15/23 7:03 AM
profile icon
206 bones Free
06/16/23 9:50 PM
profile icon
TheSprinx Free
04/20/23 11:18 AM
profile icon
TheFinalCD PremiumMember
04/19/23 7:50 AM
profile icon
TheFinalCD PremiumMember
04/19/23 7:48 AM
profile icon
TheFinalCD PremiumMember
04/19/23 5:15 AM
profile icon
TheFinalCD PremiumMember
04/18/23 4:00 PM
profile icon
TheFinalCD PremiumMember
04/18/23 3:39 PM
profile icon
TheFinalCD PremiumMember
04/18/23 3:22 PM
profile icon
Dennisb68 Free
04/18/23 3:19 PM
profile icon
TheFinalCD PremiumMember
04/18/23 2:43 PM
profile icon
Dennisb68 Free
04/18/23 2:21 PM
Bullish
Bullish
profile icon
TheSprinx Free
02/13/23 11:51 AM
profile icon
TheSprinx Free
09/29/21 9:25 PM
profile icon
ClayTrader Free
03/30/21 5:01 PM
profile icon
Dennisb68 Free
03/30/21 4:07 PM
profile icon
TheSprinx Free
03/14/21 3:10 PM
profile icon
amber818 Free
02/16/21 5:29 PM
profile icon
Andy T Free
02/16/21 2:17 PM
profile icon
TheSprinx Free
02/15/21 9:22 PM
profile icon
Chemist823 Free
02/14/21 11:28 AM
profile icon
Chemist823 Free
02/11/21 3:44 PM
profile icon
TheSprinx Free
02/10/21 7:18 AM
profile icon
TheSprinx Free
02/09/21 5:45 PM
profile icon
TheSprinx Free
02/09/21 4:53 PM
profile icon
TheSprinx Free
02/09/21 3:28 PM
profile icon
TheSprinx Free
02/09/21 2:32 PM
profile icon
TheSprinx Free
02/08/21 3:34 PM
profile icon
Wolf91 Free
02/04/21 9:36 AM
profile icon
TheSprinx Free
02/03/21 2:24 PM
profile icon
tigertiger88 Free
02/03/21 10:42 AM
profile icon
Dennisb68 Free
02/03/21 9:17 AM
profile icon
Dennisb68 Free
02/02/21 7:05 PM
profile icon
ClayTrader Free
02/02/21 5:59 PM
profile icon
TheSprinx Free
02/02/21 4:41 PM
profile icon
tigertiger88 Free
02/02/21 4:25 PM
profile icon
tigertiger88 Free
02/02/21 4:09 PM
profile icon
2020trader Free
02/02/21 1:06 PM

Moleculin Biotech Inc (MBRX) RSS Feed

Followers
89
Posters
306
Posts (Today)
0
Posts (Total)
3504
Created
06/17/16
Type
Free
Moderators
wally

WALTER V. KLEMP
President, CEO and Chairman

Company web. site  http://www.moleculin.com
   
Authorized Shares      100,000,000 as of  05/01.2020
Outstanding Shares     60,403,164  as of  05/01/2020

Quarterly Report (10-q)    May 11, 2020
https://ih.advfn.com/stock-market/NASDAQ/moleculin-biotech-MBRX/stock-news/82428874/quarterly-report-10-q

Second Quarter Earnings 2019
 https://ih.advfn.com/stock-market/NASDAQ/moleculin-biotech-MBRX/stock-news/80558492/moleculin-biotech-inc-reports-financial-results

Moleculin Presentation May 31,2019
https://ir.moleculin.com/all-sec-filings

Moleculin Announces First Patients Treated in European Annamycin Clinical Trial
https://finance.yahoo.com/news/moleculin-announces-first-patients-treated-113000512.html

Moleculin Announces the FDA has Granted Orphan Drug Designation for its Brain Tumor Drug
 https://www.otcmarkets.com/stock/MBRX/news/story?e&id=1276755

Moleculin Announces Significant Milestone Achieved in Glioblastoma Trial
https://ih.advfn.com/p.php?pid=nmona&article=78590137&symbol=MBRX


Moleculin Announces Positive Data on WP1066 in Pre-Clinical Trials
https://ih.advfn.com/p.php?pid=nmona&article=78537668&symbol=MBRX


Moleculin Announces New Data Discovery Confirming Significant Increase in Potential to Starve Cancerous Tumors
https://ih.advfn.com/p.php?pid=nmona&article=78433601&symbol=MBRX

Moleculin receives approval for leukemia clinical trial; shares ahead 23% premarket
https://seekingalpha.com/news/3365150-moleculin-receives-approval-leukemia-clinical-trial-shares-ahead-23-percent-premarket


Moleculin Targets accelerated FDA approval of WP1732; Pursues Development for Ocular Tumors
https://ir.moleculin.com/press-releases/detail/89/moleculin-targets-accelerated-fda-approval-of-wp1732
 Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial
https://globenewswire.com/news-release/2018/05/03/1495957/0/en/Moleculin-Announces-Engagement-with-Voisin-Consulting-Life-Sciences-to-Expand-Annamycin-Clinical-Trial.html

Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
https://finance.yahoo.com/news/moleculin-enters-agreement-seidman-cancer-123000495.html

Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
http://www.marketwired.com/press-release/moleculin-announces-grant-funded-collaboration-expand-understanding-new-discovery-2246407.htm

Exclusive: Moleculin CEO Says Acute Myeloid Leukemia Candidate Could Be 'Remarkable' https://www.benzinga.com/general/biotech/18/03/11260689/exclusive-moleculin-ceo-says-acute-myeloid-leukemia-candidate-could-b

 

Moleculin Biotech (MBRX) Buys Active Drug Compound for Treatment of Brain Cancer https://www.streetinsider.com/Corporate+News/Moleculin+Biotech+%28MBRX%29+Buys+Active+Drug+Compound+for+Treatment+of+Brain+Cancer/13211319.html




Moleculin Biotech, Inc. (Nasdaq: MBRX) to Ring The Nasdaq Stock Market Closing Bell in celebration of IPO

Metabasis Therapeutics (NASDAQ:MBRX)
Historical Stock Chart

Moleculin Biotech (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).

In honor of the occasion, Walter Klemp, Chief Executive Officer, will ring the Closing Bell.

Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:
Thursday, June 2, 2016 – 3:45 p.m. to 4:00 p.m. ET

Moleculin Biotech Media Contact:
Sean Leous
(646) 863-8998
sleous@pcgadvisory.com
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post